References

 

(To 5.1)

 

1.      Kutteh, W.H., 1999, Recurrent pregnancy loss: an update, Curr. Opin. Obstet. Gynecol., 11, 435.

2.      Horne, A.W., and Alexander, C.I., 2005, Recurrent miscarriage,  J. Fam. Plann. Reprod. Health Care, 3, 103.

3.      Porcu, G., Cravello, L., D'Ercole, C., Cohen, D., Roger, V., de Montgolfier, R., and Blanc, B., 2000, Hysteroscopic metroplasty for septate uterus and repetitive abortions: reproductive outcome, Eur. J. Obstet. Gynecol. Reprod Biol., 88, 81.

4.      Dendrinos, S., Makrakis, E., Botsis, D., Chassiakos, D., Baka, S., and Creatsas, G., 2005, A study of pregnancy loss in 352 women with recurrent miscarriages, Arch. Gynecol. Obstet., 271, 235.

5.      Burton, G.J., and Jauniaux, E., 2004, Placental oxidative stress: from miscarriage to preeclampsia, J. Soc. Gynecol. Investig., 11, 342.

6.      Aydin, S., Ozeren, M., Yenilmez, E., Yulug, E., Cobanoglu, U., and Arvas, H., 2006, Morphologic alterations and immunohistochemical analysis of alpha-fetoprotein and CD34 in chorionic villi of anembryonic pregnancy, Saudi Med. J., 27,154.

7.      Hempstock, J., Jauniaux, E., Greenwold, N., and Burton, G.J., 2003, The contribution of placental oxidative stress to early pregnancy failure, Hum. Pathol., 34, 1265.

8.      Tamiolakis, D., Anastasiadis, P., Hatzimichael, A., Liberis, B., Karamanidis, D., Kotini, A., Petrakis, G., Romanidis, K., and Papadopoulos, N., 2001, Spontaneous abortions with increased CD5 positive cells in the placental tissue during the first trimester of gestation, Clin. Exp. Obstet. Gynecol., 28, 261.

9.      Tan, Y.Q., Hu, L., Lin, G., Sham, J.S., Gong, F., Guan, X.Y., and Lu, G., 2004, Genetic changes in human fetuses from spontaneous abortion after in vitro fertilization detected by comparative genomic hybridization, Biol. Reprod., 70, 495.

10.    Genç, M., and Ledger, W.J., 2000, Syphilis in pregnancy, Sex Transm. Infect., 76, 73.

11.    Brocklehurst, P., and French, R., 1998, The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis, Br. J. Obstet. Gynaecol., 105, 836.

12.    Wenstrom, K.D., Andrews, W.W., Bowles, N.E., Towbin, J.A., Hauth, J.C., and Goldenberg, R.L., 1998, Intrauterine viral infection at the time of second trimester genetic amniocentesis, Obstet. Gynecol., 92, 420.

13.    Li, T.C., Spuijbroek, M.D., Tuckerman, E., Anstie, B., Loxley, M., and Laird, S., 2000, Endocrinological and endometrial factors in recurrent miscarriage, BJOG, 107, 1471.

14.    Lazarus, J.H., 2005, Thyroid disorders associated with pregnancy: etiology, diagnosis, and management, Treat. Endocrinol., 4, 31.

15.    George, L., Mills, J.L., Johansson, A.L., Nordmark, A., Olander, B., Granath, F., and  Cnattingius, S., 2002, Plasma folate levels and risk of spontaneous abortion,  JAMA, 288, 1867.

16.    Szekeres-Bartho, J., 2002, Immunological relationship between the mother and the fetus, Int. Rev. Immunol., 21, 471.

17.    Lachapelle, M.H., Miron, P., Hemmings, R., and Roy, D.C., 1996, Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome, J. Immunol.,  156, 4027. 

18.    Quenby, S., Bates, M., Doig, T., Brewster, J., Lewis-Jones, D.I., Johnson, P.M., and Vince, G., 1999, Pre-implantation endometrial leukocytes in women with recurrent miscarriage, Hum. Reprod., 14, 2386. 

19.    Clifford, K., Flanagan, A.M., and Regan, L., 1999, Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study, Hum. Reprod., 14, 2727. 

20.    Yamamoto, T., Takahashi, Y., Kase, N., and Mori, H., 1999, Proportion of CD56+3+ T cells in decidual and peripheral lymphocytes of normal pregnancy and spontaneous abortion with and without history of recurrent abortion, Am. J. Reprod. Immunol., 42, 355.

21.    Michimata, T.,  Ogasawara, M.S., Tsuda, H., Suzumori, K., Aoki, K., Sakai, M., Fujimura, M., Nagata, K., Nakamura, M., and Sato, S., 2002, Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion, Am. J. Reprod. Immunol., 47, 196.

22.    Guleria, I., and Sayegh, M.H., 2007, Maternal acceptance of the fetus: True human tolerance, J. Immunol., 178, 3345.

23.    King, A., Burrows, T.D., Hiby, S.E., Bowen, J.M., Joseph, S., Verma, S., Lim, P.B., Gardner, L., Le Bouteiller, P., Ziegler, A., Uchanska-Ziegler,  B., and Loke  Y.W., 2000, Surface expression of HLA-C antigen by human extravillous trophoblast, Placenta, 21, 376.

24.    Ishitani, A., Sageshima, N., Lee, N., Dorofeeva, N., Hatake, K., Marquardt, H., and Geraghty, D.E., 2003, Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition, J. Immunol., 171, 1376.

25.    Hunt, J.S., Vassmer, D., Ferguson, T.A., and Miller. L., 1997, Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus, J. Immunol., 158, 4122.

26.    Xu, C., Mao, D., Holers, V.M., Palanca, B., Cheng, A.M., and Molina, H., 2000, A critical role for murine complement regulator crry in fetomaternal tolerance, Science, 287, 498.

27.    Mattsson, R., 1998, The non-expression of MHC class II in trophoblast cells, Am. J. Reprod. Immunol., 40, 383.

28.    Rogers, A.M., Boime, I., Connolly, J., Cook, J.R., and Russell, J.H., 1998, Maternal-fetal tolerance is maintained despite transgene-driven trophoblast expression of MHC class I, and defects in Fas and its ligand, Eur. J. Immunol., 28, 3479.

29.    Ait-Azzouzene, D., Caucheteux, S., Tchang, F., Wantyghem, J., Moutier, R., Langkopf, A., Gendron, M.C., and Kanellopoulos-Langevin, C., 2001, Transgenic major histocompatibility complex class I antigen expressed in mouse trophoblast affects maternal immature B cells, Biol. Reprod., 65, 337. 

30.    Croy, B.A., Ashkar, A.A., Minhas, K., and Greenwood, J.D.,  2000, Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia?  J. Soc. Gynecol. Investig., 7, 12.

31.    Moffett-King, A., 2002, Natural killer cells and pregnancy, Nat. Rev. Immunol., 2, 656. 

32.    Hunt, J.S., Petroff, M.G., McIntire, R.H., and Ober, C., 2005, HLA-G and immune tolerance in pregnancy, FASEB J., 19, 681.

33.    Kapasi, K., Albert, S.E., Yie, S., Zavazava, N., and Librach, C.L., 2000, HLA-G has a concentration-dependent effect on the generation of an allo-CTL response, Immunology, 101, 191. 

34.    Contini, P., Ghio, M., Poggi, A., Filaci, G., Indiveri, F., Ferrone, S., and Puppo, F., 2003, Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation, Eur. J. Immunol., 33,125.

35.    Fournel, S., Aguerre-Girr, M., Huc, X., Lenfant, F., Alam, A., Toubert, A., Bensussan, A., Le Bouteiller, P., 2000, Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8, J. Immunol., 164, 6100.

36.    Mor, G., Gutierrez, L.S., Eliza, M., Kahyaoglu, F., and Arici, A.,  1998, Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease, Am. J. Reprod. Immunol., 40, 89. 

37.    Qiu, Q., Yang, M., Tsang, B.K., and Gruslin, A., 2005, Fas ligand expression by ma-ternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface, J. Reprod. Immunol., 65, 121. 

38.    Allison, J., Georgiou, H.M., Strasser, A., Vaux, D.L., 1997, Transgenic expression of CD95 ligand on islet cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts, Proc. Natl. Acad. Sci. USA, 94, 3943.

39.    Kang, S.M., Braat, D., Schneider, D.B., O’Rourke, R.W., Lin, Z., Ascher, N.L., Dichek, D.A., Baekkeskov, S., and Stock, P.G., 2000, A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants, Transplantation, 69, 1813.

40.    Vacchio, M.S., and Hodes, R.J., 2005, Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy, J. Immunol., 174, 4657.

41.    Abrahams, V.M., Straszewski-Chavez, S.L., Guller, S., and Mor, G., 2004, First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis, Mol. Hum. Reprod., 10, 55.  

42.    Frangsmyr, L., Baranov, V., Nagaeva, O., Stendahl, U., Kjellberg, L., and Mincheva-Nilsson, L., 2005, Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level, Mol. Hum. Reprod., 11, 35. 

43.    Holmes, C.H., and Simpson, K.L., 1992, Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship, Baillieres Clin. Obstet. Gynaecol., 6, 439. 

44.    von Landenberg, P., Matthias, T., Zaech, J., Schultz, M., Lorber, M., Blank, M., and Shoenfeld, Y., 2003, Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome, Am. J. Reprod. Immunol., 49, 51.

45.    Cowchock, S., 1998, Treatment of antiphospholipid syndrome in pregnancy, Lupus, 7 Suppl 2, S95.

46.    Shoenfeld, Y., Carp, H.J., Molina, V., Blank, M., Cervera, R., Balasch, J., Tincani, A., Faden, D., Lojacono, A., Doria, A., Konova, E., and Meroni, P.L., 2006, Autoantibodies and prediction of reproductive failure, Am. J. Reprod. Immunol., 56, 337.

(To 5.2)

 

47.    Wang, X., Matsumoto, H., Zhao, X., Das, S.K., and Paria, B.C.,  2004, Embryonic signals direct the formation of tight junctional permeability barrier in the decidualizing stroma during embryo implantation, J. Cell. Sci.,   117(Pt 1), 53.

48.    Griebel, C.P., Halvorsen, J., Golemon, T.B., and Day, A.A., 2005, Management of spontaneous abortion, Am. Family Physician, 72, 1243.

49.    Koch, C.A., and Platt, J.L., 2003, Natural mechanisms for evading graft rejection: the fetus as an allograft, Springer Semin. Immunopathol., 25, 95.

50.    Bulla, R., Fischetti, F., Bossi, F., and Tedesco, F., 2004, Feto-maternal immune interaction at the placental level, Lupus, 13, 625.

51.    Saito, S., 2000, Cytokine network at the feto-maternal interface, J. Reprod. Immunol., 47, 87.

52.    Gaunt, G., and Ramin, K., 2001, Immunological tolerance of the human fetus, Am. J. Perinatol., 18, 299.

53.    Le Bouteiller, P., and Mallet, V.,  1997, HLA-G. and pregnancy, Rev. Reprod., 2, 7.

54.    Weetman, A.P., 1999, The immunology of pregnancy, Thyroid,   9, 643.

55.    Hammer, A., Hutter, H., and Dohr, G., 1997, HLA class I expression on the materno–fetal interface, Am. J. Reprod. Immunol., 38, 150.

56.    Proll, J., Blaschitz, A., Hutter, H., and Dohr, G.,  1999, First trimester human endovascular trophoblast cells express both HLA-C and HLA-G, Am. J. Reprod. Immunol., 42, 30.

57.    Hammer, A., and Dohr, G.,  2000, Expression of Fas-ligand in first trimester and term human placental villi, J. Reprod. Immunol.,  46, 83.

58.    Prescott, S., Macaubas, C., Holt, B., Smallacombe, T.B., Loh, R., Sly, P.D., and Holt, P.G.,  1998, Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T-cell responses towards Th-2 cytokine profile. J. Immunol.,   160, 4730.

59.    Prescott, S.L., Taylor, A., Roper, J., Wahdan, A., Noakes, P., Thornton, C., Dunstan, J., and Upham, J.W., 2005, Maternal reactivity to fetal alloantigens is related to newborn immune responses. and subsequent allergic disease. Clin.  Exp. Allergy, 35, 417.

60.    Carosella, E.D., 2000, HLA-G: fetomaternal tolerance, C.R. Acad. Sci. III,  323, 675.

61.    Saito, S., Umekage, H., Sakamoto, Y., Sakai, M., Tanebe, K., Sasaki, Y., and Morikawa, H.,  1999, Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am. J. Reprod. Immunol.,   41, 297.

62.    Poole, J.A., and Claman, H.N., 2004 Immunology of pregnancy. Implications for the mother, Clin. Rev. Allergy Immunol., 26, 161.

63.    Coumans, B., Thellin, O., Zorzi, W., Melot, F., Bougoussa, M., Melen, L., Zorzi, D., Hennen, G., Igout, A., and Heinen, E., 1999, Lymphoid cell apoptosis induced by trophoblastic cells: a model of active foeto-placental tolerance, J. Immunol. Methods, 224, 185.

64.    Jerzak, M., and Bischof, P., 2002, Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodeling, Eur. J. Obstet. Gynecol. Reprod. Biol.,  100, 138. 

65.    Milasinovic, L., Bulatovic, S., Ilic, D., Ivanovic, L., and Zupanski, M., 2002, Adaptation of the immune system as a response to pregnancy, Med. Pregl., 55, 305.

66.    King, A., Hiby, S.E., Gardner, L., Joseph, S., Bowen, J.M., Verma, S., Burrows, T.D., and Loke, Y.W.,  2000, Recognition of trophoblast HLA class I molecules by decidual NK cell receptors--a review, Placenta, 21 Suppl A, S81.

67.    Yip, L., McCluskey, J., and Sinclair, R.,  2006, Immunological aspects of pregnancy, Clin. Dermatol., 24, 84.

68.    Ohshima, K., Nakashima, M., Sonoda, K., Kikuchi, M., and Watanabe, T.,  2001, Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege, Clin.  Exp.Immunol., 123, 481.

69.    Harris, J.M., White, C., Moffat, S., Mills, P., Newman-Taylor, A.J., and Cullinan, P., 2004, New pregnancies and loss of allergy. Clin. Exp. Allergy,  34, 369.

70.    Barrat, F., Lesourd, B., Boulouis, H.J., Thibault, D., Vincent-Naulleau, S., Gjata, B., Louise, A., Neway, T., and Pilet, C., 1997, Sex and parity modulate cytokine production during murine ageing. Clin. Exp. Immunol., 109, 562.

71.    Moore, J.M., Nahlen, B.L., Misore, A., Lal, A.A., and Udhayakumar, V., 1999, Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria. J. Infect. Dis.,  179,1218. 

72.    Prescott, S., Macaubas, C., Smallacombe, T., Holt, B.J., Sly, P.D., and Holt, P.G., 1999, Development of allergen-specific T-cell memory in atopic and normal children. Lancet,   353, 196.

73.    Williams, T.J., Jones, C.A., Miles, E.A., Warner, J.O., and Warner, J.A.,  2000, Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J. Allergy Clin. Immunol., 105, 951.

74.    Prescott, S., Jenmalm, M., Bjorksten, B., and Holt, P.,  2000, Effects of maternal allergen-specific IgG in cordblood on early postnatal development of allergen-specific T-cell immunity. Allergy,  55, 470.

75.    Martinez, F.D.,  1997, Maternal risk factors in asthma. Ciba Found. Symp.,  206, 233.

76.    Hanson, L.A., Korotkova, M., Lundin, S., Haversen, L., Silfverdal, S.A., Mattsby-Baltzer, I., Strandvik, B., and Telemo, E., 2003, The transfer of immunity from mother to child.  Ann.  N.Y. Acad.  Sci.,  987, 199.

77.  Schelonka,  R.L.,  and Infante, A.J., 1998, Neonatal immunology. Semin. Perinatol., 22, 2.

78.    Adkins,  B.,  1999, T-cell function in newborn mice and humans. Immunol.  Today,  20, 330.

 

(To 5.3)

 

79.    Tedesco, F., Pausa, M., Bulla, R., Melazzini, S., and Guaschino, S., 1997, The maternal-fetal immune relationship in pregnancy, Recenti Prog. Med., 88, 406.

80.    Bulla, R., Fischetti, F., Bossi, F., and Tedesco, F., 2004, Feto-maternal immune interaction at the placental level, Lupus, 13, 625.

81.    Ness, R.B.,  2004, The consequences for human reproduction of a robust inflammatory response, Q. Rev. Biol., 79, 383.

82.    de Luca Brunori, I., Battini, L., Brunori, E.,  Lenzi, P., Paparelli, A., Simonelli, M., Valentino, V., and Genazzani, A.R.,  2005, Placental barrier breakage in preeclampsia: ultrastructural evidence, Eur. J. Obstetr. Gynecol.  Reprod.  Biol.,   118, 182.

83.    Huddleston, H.,  and Schust, D.J., 2004, Immune interactions at the maternal-fetal interface: a focus on antigen presentation, Am. J. Reprod. Immunol.,  51, 283.

84.    Gurevich, P., Erina, S., Gershon, S., and Zusman, I.,  1997, The role of  the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns, Human Antibodies, 8, 76.

85.    Sargent, I.L.,1993,  The placenta and recurrent early pregnancy loss, In:  The Human Placenta, A Guide for Clinicians and Scientists, C.W.G. Redman, I.L. Sargent, and P.M. Starkey  (Eds.), Blackwell Sci.  Publ., Oxford, UK,   113.

86.    Tamiolakis, D., Anastasiadis, P., Hatzimichael, A., Liberis, B., Karamanidis, D., Kotini, A., Petrakis, G., Romanidis, K., and Papadopoulos, N., 2001, Spontaneous abortions with increased CD5 positive cells in the placental tissue during the first trimester of gestation, Clin. Exp. Obstet. Gynecol., 28, 261.

87.    Chan, C.C., Lao, T.T., and Cheung, A.N., 1999, Apoptotic and proliferative activities in first trimester placentae, Placenta,  20, 223.

88.    Ben-Hur, H., Gurevich, P., Elhayany, A., Avinoach, I., Schneider, D.F., and Zusman, I., 2005, Transport of maternal immunoglobulins through the human placental barrier in normal pregnancy and during inflammation, Int. J. Mol. Med., 16, 401.

89.    Gurevich, P.,  Elhayany, A., Milovanov, A.P., Halperin, R.,  Kaganovsky, E.,

       Zusman, I.,   and Ben-Hur,   H., 2007, The placental barrier in allogenic  immune

       conflict in spontaneous early abortions: Immunohistochemical and morphological    study, Am. J. Reprod. Immunol., 58, 460.

90.    Kokawa, K., Shikone, T., and Nakano, R.,  1998, Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester, Placenta,   19, 21.

91.    Bulla, R., Bossi, F., Radillo, O., de Seta, F., and Tedesco, F., 2003, Placental trophoblast and endothelial cells as target of maternal immune response, Autoimmunity,    36, 11.

92.    Uchide, N., Ohyama, K., Bessho, T.,  and Toyoda, H.,  2005, Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection, Med. Sci. Monit., 11, RA7.

93.    Eguchi, Y., Shimizu, S.,  and Tsujimoto, Y.,  1997, Intracellular ATP levels determine cell death fate by apoptosis or necrosis, Cancer Res.,    57, 1835.

94.    Smith, S.C., Price, E., Hewitt, M.J., Symonds, E.M., and Baker, P.N., 1998, Cellular proliferation in the placenta in normal human pregnancy and pregnancy complicated by intrauterine growth restriction, J. Soc. Gynecol. Invest.,  5, 317.

95.    Levy, R., Smith, S.D., Yusuf, K., Huettner, P.C., Kraus, F.T., Sadovsky, Y., and Nelson, D.M.,  2002, Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression, Am. J. Obstet. Gynecol.,186, 1056.